Approval · Notice of Compliance 9904 · 2008
OLMETEC PLUS: Notice of Compliance 9904
Issued November 21, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9904
- Date
- November 21, 2008
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin ii at1 receptor blocker / diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OLMETEC PLUS | 02319616 | Marketed |
| OLMETEC PLUS | 02319624 | Marketed |
| OLMETEC PLUS | 02319632 | Marketed |
Medicinal ingredients
- OLMESARTAN MEDOXOMIL 20 MG per TAB
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- OLMESARTAN MEDOXOMIL 40 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB